Geriatric Assessment in Oncology: G8 Screening Tool Validation and Reliability Study

Abstract

OBJECTIVEThe present study aimed to test the validity and reliability of the Geriatrics 8 (G8) tool, a risk-screening toolfor further comprehensive geriatric assessment, with hematologic cancer patients aged 65 years and older.METHODSThis methodological study included 110 patients followed up for hematologic cancer. Data were collected using the patient identification form, the G8 screening tool, and the Edmonton Frail Scale. Languageand content validity, internal consistency, confirmatory factor, sensitivity and specificity and concurrentvalidity analyses were also used.RESULTSPatients (mean age: 73.9±6.10) were diagnosed with lymphoma (30.9%), multiple myeloma (21.8%),leukemia (20.9%), myelodysplastic syndrome (19.1%). Confirmatory factor model fit index analysis χ²/df and p-values (0.14) showed a good fit and GFI, AGFI, SRMR, and RMSEA values showed acceptablefit. The Cronbach’s alpha coefficient was 0.655, area under the ROC curve was 0.824 (95%, 0.745–0.904),and sensitivity and specificity were 61.0% and 88.9%, respectively.CONCLUSIONThe findings indicated that the G8 screening tool was found a valid and reliable tool for geriatric patientsdiagnosed with cancer to determine the risk and need for further comprehensive geriatric assessment.